版本:
中国

BRIEF-Biohaven completes enrollment in Spinocerebellar Ataxia clinical trial with Trigriluzole

May 30 Biohaven Pharmaceutical Holding Company Ltd

* Biohaven completes enrollment in Spinocerebellar Ataxia clinical trial with Trigriluzole

* Biohaven completes enrollment in Spinocerebellar Ataxia clinical trial with Trigriluzole

* Says "we expect to submit a new drug application to FDA in early 2018." Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐